25 /100
LOW RISK
Score updated May 30, 2026

SYRA — Syra Health Corp. Dilution Risk Tracker

Track SYRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SYRA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
39%
🔄 Reverse Split 55%
• 50-day avg $0.39 below $1 exchange minimum
🔁 Convertible Conversion 40%
• Significant convertible debt: 22% potential dilution
• Elevated convertible risk (60/100)
🔔 Track SYRA — Get forecast alerts →

💹 Market Data

Market Cap$6.57M
Shares Outstanding11.34M
FloatN/A
Cash$2.92M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest115.8K
Days to Cover2.5
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
4 INSIDER TRANSACTION Feb 03, 2026
3 FORM3 Jan 14, 2026
3 FORM3 Jan 13, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track SYRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SYRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADT
🔬 More Research for SYRA
📊 SYRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SYRA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.